These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9854009)

  • 1. [Idiopathic thrombopenic purpura in a child in black Africa: a case report in Togo].
    Gbadoé AD; Messie K; Atakouma DY; Vovor A; Tatagan-Agbi K; Késsié K; Vilmer E; Assimadi JK
    Sante; 1998; 8(5):337-41. PubMed ID: 9854009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of idiopathic thrombopenic purpura in two pediatric services of Antananarivo city].
    Rasamoelisoa JM; Tovone XG; Andriamady RC; Razafimandimby H; Rasamindrakotroka A
    Arch Inst Pasteur Madagascar; 1999; 65(1-2):110-2. PubMed ID: 12478974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
    Van Riet FA; Wessels G; Hesseling PB
    East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenia purpura.
    Hunt CW
    Medsurg Nurs; 2010; 19(4):237-9. PubMed ID: 20860250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
    Liebman HA
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
    Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG
    Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of chronic idiopathic thrombocytopenic purpura.
    ElAlfy M; Farid S; Abdel Maksoud A
    Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura.
    Segel GB; Feig SA
    Pediatr Blood Cancer; 2009 Sep; 53(3):318-24. PubMed ID: 19165890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ; Buchanan GR
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of childhood immune thrombocytopenic purpura.
    Tarantino M
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.